GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Research & Development

IMGT (XKRX:456570) Research & Development : ₩3,429.23 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is IMGT Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. IMGT's Research & Development for the six months ended in Dec. 2023 was ₩3,429.23 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was ₩3,429.23 Mil.

IMGT Research & Development Historical Data

The historical data trend for IMGT's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Research & Development Chart

IMGT Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Research & Development
2,136.63 3,997.49 4,856.58 3,429.23

IMGT Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Research & Development 2,136.63 3,997.49 4,856.58 3,429.23

IMGT Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was ₩3,429.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMGT  (XKRX:456570) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

IMGT Research & Development Related Terms

Thank you for viewing the detailed overview of IMGT's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

IMGT Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Research & Development
Comparable Companies
XKRX:036480 XKRX:208340 XKRX:115180 XKRX:344860 XKRX:383930 XKRX:298060 XKRX:065650 XKRX:299660 XKRX:179530 XKRX:142760 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605
Website
http://www.imgt.co.kr
IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT Headlines

No Headlines